Platelet inhibition with prasugrel in patients with acute myocardial infarction undergoing therapeutic hypothermia after cardiopulmonary resuscitation.

@article{Flierl2016PlateletIW,
  title={Platelet inhibition with prasugrel in patients with acute myocardial infarction undergoing therapeutic hypothermia after cardiopulmonary resuscitation.},
  author={Ulrike Flierl and Philipp Roentgen and Florian Zauner and Joern Tongers and Dominik Berliner and Johann Bauersachs and Andreas Schaefer},
  journal={Thrombosis and haemostasis},
  year={2016},
  volume={115 5},
  pages={960-8}
}
Acute myocardial infarction (AMI) is the leading cause for out-of-hospital cardiac arrest. Therapeutic hypothermia improves neurological outcome in combination with early revascularisation, but seems to affect clopidogrel responsiveness. The more potent thienopyridine prasugrel has not yet been sufficiently evaluated during therapeutic hypothermia. We… CONTINUE READING